Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study

ERJ Open Res. 2021 Feb 7;8(1):00542-2021. doi: 10.1183/23120541.00542-2021. eCollection 2022 Jan.

Abstract

Patients receiving N-acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo.